Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Baird Medical Investment Holdings Limited (BDMDW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: BDMDW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -70.83% | Avg. Invested days 31 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.7 | 52 Weeks Range 0.02 - 0.20 | Updated Date 06/3/2025 |
52 Weeks Range 0.02 - 0.20 | Updated Date 06/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 37.96% | Operating Margin (TTM) 38.74% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10638416 |
Shares Outstanding - | Shares Floating 10638416 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Baird Medical Investment Holdings Limited
Company Overview
History and Background
Baird Medical Investment Holdings Limited is a medical device company. The company was formerly known as Skytronics Limited and changed its name to Baird Medical Investment Holdings Limited in July 2020. The company focuses on research and development, production, and sales of medical devices. Details on founding year, significant milestones, and evolution over time are limited in publicly available sources.
Core Business Areas
- Medical Device Manufacturing and Sales: Baird Medical develops, manufactures, and sells medical devices across different medical disciplines. Specific device types are difficult to ascertain from public data but focus likely includes interventional and surgical products
Leadership and Structure
Information regarding specific leadership team members and organizational structure is not readily available in public sources.
Top Products and Market Share
Key Offerings
- Medical Devices: Details about specific product lines and their market share are limited in publicly available information. Baird Medical focuses on interventional and surgical devices, but further segmentation is unavailable. Competitors depend upon market segment.
Market Dynamics
Industry Overview
The medical device industry is growing with technological advances, aging populations, and rising healthcare expenditure. The market is highly competitive and regulated. Growth is driven by innovation, minimally invasive procedures, and personalized medicine.
Positioning
Due to lack of market share, it's difficult to assess Baird Medical's position. Baird may be positioning towards serving specific sub-markets to find niches for growth. Competitive advantages not readily apparent from publicly available data.
Total Addressable Market (TAM)
The global medical device market is estimated to be worth several hundred billion dollars. Baird Medical's TAM is dependent on specific product focuses. Further analysis is required to understand Baird's penetration of its target TAM.
Upturn SWOT Analysis
Strengths
- Focus on Medical Devices
- Potentially serves a niche market within medical devices
- Experienced management team (unconfirmed)
Weaknesses
- Limited information available publicly
- Small market cap
- Unclear product portfolio
- Limited geographical presence
Opportunities
- Expansion into new geographic markets
- Development of innovative medical devices
- Partnerships with other medical companies
- Increased healthcare spending in emerging markets
Threats
- Intense competition from established medical device companies
- Stringent regulatory requirements
- Technological advancements rendering products obsolete
- Economic downturn affecting healthcare spending
Competitors and Market Share
Key Competitors
- JNJ
- BSX
- MDT
Competitive Landscape
Baird Medical faces intense competition from larger, more established medical device companies. Its competitive advantage is unclear without detailed product and market information. Further competitive benchmarking is needed.
Growth Trajectory and Initiatives
Historical Growth: Insufficient data to assess historical growth trends.
Future Projections: No available analyst estimates for future growth projections.
Recent Initiatives: No publicly available information on recent strategic initiatives.
Summary
Baird Medical Investment Holdings Limited is a small player in the highly competitive medical device industry. Due to data limitations, it is challenging to assess Baird's strengths and weaknesses. More information on Baird's target markets and core products are needed to better understand it's potential. Public sources lack adequate information and financial data making it difficult to judge the health of the company. The company is positioned to take advantage of the Medical Device industry as a whole.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Yahoo Finance
- Company Website
- SEC Filings (limited available data)
Disclaimers:
The information provided is based on publicly available data and may not be entirely accurate or complete. This analysis is not financial advice and should not be used as the sole basis for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Baird Medical Investment Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-10-02 | Chairwoman of the Board of Directors & CEO Ms. Haimei Wu | ||
Sector Healthcare | Industry Medical Devices | Full time employees 143 | Website https://bairdmed.com |
Full time employees 143 | Website https://bairdmed.com | ||
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. It offers microwave ablation apparatus and needles, as well as microwave ablation apparatus approved for the treatment of live cancer and thyroid nodules, long microwave ablation needles, and fine microwave ablation needles through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.